Background. Ambulatory outpatients (n=150) with a history of paroxysmal supraventricular arrhythmia were studied to establish the characteristics of the first recurrence of symptomatic tachycardia (time to first recurrence, heart rate during tachycardia, and observed rhythm that was regular versus irregular) when no antiarrhythmic drug was being taken. Baseline variables were examined to assess their impact on time to first recurrence: index arrhythmia (paroxysmal atrial fibrillation [n=37J versus paroxysmal supraventricular tachycardia [n =113]), age (mean± SD, 43.3±16.1 years), female sex (n=71), or presence of other heart or lung disease (n=53).
P aroxysmal supraventricular arrhythmias are frustrating disorders for patients and physicians. Their sporadic and transient nature may result in delayed diagnosis and difficulty in assessing antiarrhythmic drug effects. These arrhythmias can be classified by ECG criteria and by electrophysiological criteria obtained with intracardiac recording and programmed electrical stimulation, but little is known about the value of these classifications in predicting differences in the occurrence of the arrhythmias. The purpose of this study, therefore, was to assess the impact of arrhythmia classification and other clinical variables on the spontaneous occurrence of paroxysmal supraventricular arrhythmias in untreated patients. Methods
Patient Sample
We studied a consecutive series of 150 patients (79 men and 71 women) referred to the Clinical Research Unit Arrhythmia Clinic between 1980 and 1991 who met ECG criteria for paroxysmal supraventricular tachycardia or paroxysmal atrial fibrillation and who underwent an observation period during which they received no antiarrhythmic drug treatment. The ECG criteria for paroxysmal supraventricular tachycardia were a ventric- PSVT, paroxysmal supraventricular tachycardia; PAF, paroxysmal atrial fibrillation.
*Total patients with any of the heart or lung diseases listed. A patient could have more than one heart or lung disease.
ular rhythm with a rate > 120 beats per minute, a QRS morphology during tachycardia that was either normal or functional bundle branch block, <20 msec variation in successive RR intervals, no evidence of atrioventricular dissociation, and episodic occurrence. The ECG criteria for paroxysmal atrial fibrillation were a grossly irregular ventricular rhythm, a QRS morphology during arrhythmia that was either normal or functional bundle branch block, the absence of identifiable P waves when they had been obvious on ECGs during sinus rhythm, and episodic occurrence. On the basis of these criteria, the "index arrhythmia" for each patient was classified as either paroxysmal supraventricular tachycardia or paroxysmal atrial fibrillation.
Other information obtained at the time of referral included demographic variables, a description of any other heart or lung disease present, and the results of electrophysiology studies when they were available. In addition to their paroxysmal supraventricular arrhythmia, 53 patients had at least one other heart or lung disease, including 18 with valvular heart disease, 17 with hypertension, and seven with chronic obstructive lung disease (Table 1) . Twenty-four of the patients (all with paroxysmal supraventricular tachycardia) had an ECG recorded during sinus rhythm that showed a short PR interval and a delta wave on the QRS complex consistent with the Wolff-Parkinson-White syndrome. None of the patients could reliably trigger his or her arrhythmia by any specific activity, beverage, or food.
Fifty-six of the patients with paroxysmal supraventricular tachycardia underwent electrophysiology study with intracardiac recording and programmed stimulation to establish the mechanism of their arrhythmia1; these electrophysiology studies were done for clinical indications rather than for research purposes. On the basis of the results of the electrophysiology studies, paroxysmal supraventricular tachycardia was subclassified by mechanism as being caused by atrioventricular nodal reentry, atrioventricular reentry, atrial tachycardia, or unknown if no tachycardia was induced.
The patients included in this report represented a broad mix of past medical treatment. For example, some patients were referred because they were employees of the institution, and it was therefore convenient for the patients and their primary care physicians to have them seen by a specialist; other patients were referred after having been seen by several other cardiologists in other institutions because of the availability here of consultants with a special interest in arrhythmias. The patients reported having had symptoms for a median of 9.3 years (range, 0.0-69.8 years) before participating in this study. The median number of antiarrhythmic drugs to which the patients had been exposed was two (range, zero to nine). Additional observations on some of these patients have been reported previously. There were three outcome variables of interest: 1) the length of time in days from the beginning of the drug-free observation period to the first recurrence of paroxysmal supraventricular arrhythmia; 2) the heart rate during that arrhythmia; and 3) the time of day that the arrhythmia occurred. Primary analyses assessed the effects of age, sex, and the presence of other heart or lung disease on these outcome variables and compared the distributions of the outcome variables between the patients whose index arrhythmia was paroxysmal supraventricular tachycardia and those whose index arrhythmia was paroxysmal atrial fibrillation.
Secondary analyses compared the distributions of recurrence time and heart rate during arrhythmia within three classifications of the patients whose index arrhythmia was paroxysmal supraventricular tachycardia: 1) patients with and without the Wolff-Parkinson-White syndrome, 2) patients with electrophysiology studies whose arrhythmia mechanism was atrioventricular reentry and those whose mechanism was atrioventricular nodal reentry, and 3) patients whose mechanism was atrioventricular reentry with conduction over an accessory pathway in both antegrade and retrograde directions and those with conduction only in the retrograde direction.
We used the Kaplan-Meier product-limit method to estimate and to illustrate graphically the proportion of patients remaining free of arrhythmia on each day of the drug-free observation period.6 The proportional-hazards model was used to assess the effect of age on the recurrence-time distribution and to compare the recurrence-time distributions between subgroups of patients with and without adjustment for potential confounders (age, sex, and the presence of other heart or lung disease).7 The magnitude of these effects is expressed in terms of the hazard ratio (HR), the constant ratio of two proportional-hazard functions representing instantaneous risks of arrhythmic recurrences. Since recurrences of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation behave, in general, like Poisson processes, this HR is equivalent to the ratio of the frequency with which these arrhythmias occur during long follow-up periods. 8, 9 For the patients who experienced a symptomatic episode of paroxysmal supraventricular arrhythmia, comparisons of heart rate during arrhythmia between subgroups were made with two-sample t tests; linear regression models were used to adjust these comparisons for potential confounders. The confidence intervals for proportions are exact binomial confidence intervals.
The time of day that the episode occurred was categorized into six 4-hour intervals beginning at midnight to determine whether distribution of the time of episode was consistent with a discrete uniform distribution, implying a constant risk of episode throughout the day. This categorization was also used to analyze the relation of time of episode to age, sex, and the presence of other heart or lung disease. The consistency of the higher risk of other heart and lung disease in atrial fibrillation compared with supraventricular tachycardia across these 4-hour intervals was evaluated with the x2 statistic for testing the homogeneity of the odds ratios. 10 For each of the two index arrhythmias, the relative frequency of episodes within each of twelve 2-hour intervals beginning at midnight was used in a linear regression model to estimate a sinusoidal density function with a period of 24 hours:
or, equivalently, f(t)=,80+81 sin(2rt/24)+,f2 cos(2,wt/24), 0<t<24
The departure of this density function from the uniform density on the 24-hour interval was tested by ANOVA for the regression model; the two densities were also compared directly with each other by a single regression model containing an indicator variable for the index arrhythmia and interaction terms between this indicator and the two trigonometric terms.
Results

Length of Time to Recurrence of Supraventricular Arrhythmia
Of the 150 patients in the study population, 126 experienced a symptomatic episode of paroxysmal supraventricular arrhythmia during the drug-free observation period that was observed and documented by ECG by use of the telephone monitor system. Twenty-five percent of the patients had an episode of symptomatic tachycardia by day 4 and 50% by day 23 ( Figure 1A) .
Age was significantly associated with the time to a symptomatic episode (p<0.001); the estimated increase in the hazard function associated with 10 years of advancing age was 25%. The recurrence-time distributions for the older and younger halves of the study population are illustrated in Figure 1B . Although the presence of other heart or lung disease appeared to be associated with the time to an episode ( Figure 1C) a symptomatic episode, either before or after adjustment for age (HR=O.9,p>0.4 in both models).
Of the 150 patients followed during an antiarrhythmic drug-free observation period, 113 had paroxysmal supraventricular tachycardia as their index arrhythmia, and 37 had paroxysmal atrial fibrillation. The patients with atrial fibrillation were significantly older (p<0.001) and had a significantly higher prevalence of other heart or lung disease (p=0.05) than the patients whose index arrhythmia was supraventricular tachycardia ( Table 1) . The estimated recurrence-time distributions for the two index arrhythmias are shown in Figure 1D ; atrial fibrillation as an index arrhythmia was associated with significantly shorter recurrence times (HR= 1.6, p<0.03). However, the difference in the recurrence time distributions between the two groups was no longer significant after adjustment for the effect of age (HR= 1.3, p>0.2). Furthermore, there was no evidence that the age effect differed between the two index arrhythmias (Figure 2) .
In an analysis containing both index arrhythmias, the interaction between age and the index arrhythmia was not significant (x2=0.3,p>0.5). In separate analyses for the two index arrhythmias, the HR for each year of advancing age was 1.02 for both.
Among the 113 patients with paroxysmal supraventricular tachycardia, 24 Age was significantly correlated with heart rate during observed arrhythmia (r= -0.34,p<0.001), heart rate decreasing with advancing age. Although the mean heart rate was lower in patients with other heart or lung disease than in those without other heart or lung disease (mean heart rates, 168.3 and 183.2 beats per minute, respectively), the difference was not significant either before (p=0.08) or after (p>0.5) adjustment for age. The difference in heart rate during observed arrhythmia for men and women (mean, 173.6 and 182.8 beats per minute, respectively) was not significant.
In a comparison of heart rates of observed arrhythmias that were concordant with the index arrhythmia (i.e., regular ventricular rhythm when the index arrhythmia was paroxysmal supraventricular tachycardia and irregular ventricular rhythm when the index arrhythmia was atrial fibrillation), the mean heart rate during regular ventricular rhythms was significantly greater than the mean heart rate during irregular ventricular rhythms (age-adjusted mean heart rates, 196.0 and 135.5 beats per minute, respectively; p<0.001) ( Table 2 ).
In the patients whose index arrhythmia was paroxysmal supraventricular tachycardia, the mean heart rate during an observed episode with a regular ventricular rhythm was significantly greater than that during an episode with an irregular ventricular rhythm (age-adjusted mean heart rates, 197. 4 Clock Time (hours) FIGURE 4. Relative frequency histogram for the occurrence ofparoxysmal supraventricular tachycardia (upperpanel) and paroxysmal atrial tachycardia (lower panel). The density function (smooth curve) was sinusoidal for paroxysmal supraventricular tachycardia but not for paroxysmal atrial fibrillation.
prevalence of 55.6% among those whose episodes occurred between midnight and 4 AM. Based on the relative frequency of episodes in twelve 2-hour intervals beginning at midnight, the estimated sinusoidal density function for the time of episode in paroxysmal supraventricular tachycardia was f(t)=0.0417-0.0195 sin(2irt/24)-0.0070 cos(2 rrt/24) and this density was significantly different from the uniform density (F29=9.08, p<0.01). The maximum incidence of episode in paroxysmal supraventricular tachycardia (the maximum of the density function) occurs at approximately 6 PM; the incidence there is 2.75 times the minimum incidence at 6 AM ( Figure 4) .
The corresponding density for the time of episode in atrial fibrillation was f(t)=0.0417+0.0018 sin(2irt/24)-0.0089 cos(2lrt/24) but this density was not significantly different from the uniform density (F2,9= 1.60, p>0.2). Furthermore, these two density functions were significantly different from each other (F2,18=4.61, p<0.03) and there was no evidence that the difference was attributable to the effect of other heart and lung disease, because the higher risk of other heart and lung disease associated with atrial fibrillation was consistent across the six 4-hour intervals (X2s=3.01, p>0.7). Discussion This study reports several important new insights into the spontaneous occurrence of symptomatic paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. We found that among the many factors that could influence the occurrence of these arrhythmias, age was most important. Older patients had symptomatic recurrences of their arrhythmias significantly sooner after beginning a drug-free observation period. Symptomatic arrhythmias also occurred sooner in the subgroup of patients with paroxysmal atrial fibrillation than in those having paroxysmal supraventricular tachycardia, but age differences in the subgroups accounted for this apparent effect of arrhythmia mechanism. There was a substantial discordance between the diagnosis of the index arrhythmia made at the start of the study and the arrhythmia observed during the study. We found differences in heart rates among observed arrhythmias, regular tachycardias being uniformly faster than irregular tachycardias. In addition, we found no evidence for a sinusoidal circadian pattern in the occurrence of paroxysmal atrial fibrillation, in contrast to the sinusoidal density function that described the circadian occurrence of paroxysmal supraventricular tachycardia.
Length of Time to the Occurrence of Supraventricular Arrhythmia
In our study of untreated patients who were known to have paroxysmal supraventricular arrhythmias, the patient's age was the clinical characteristic most closely associated with the tachycardia-free period. We found that 10 years of age was associated with a 25% increase in the hazard function. This suggests that a 30-year increase in age would be associated with a doubling of the frequency of arrhythmia episodes. Since our study was cross-sectional rather than longitudinal, we do not know whether the age effect represents arrhythmia progression in individual patients, a cohort effect, or a distinctive referral pattern in our population. If it represents a longitudinal effect, then young patients with paroxysmal supraventricular arrhythmias can expect to experience more frequent arrhythmias as they get older. Confirmation that this is indeed a longitudinal effect would provide some rationale for early intervention with radiofrequency ablation in patients with paroxysmal supraventricular tachycardia.
Paroxysmal atrial fibrillation was associated with shorter tachycardia-free periods than paroxysmal supraventricular tachycardia, but this difference was attributable to the differences in age between the two groups. Moreover, the specific mechanism of the paroxysmal supraventricular tachycardia determined by electrophysiology study ( This discordance between the index arrhythmia and the observed arrhythmia had an important impact on the heart rate during observed tachycardia: regular rhythms were substantially faster than irregular rhythms in all comparisons ( Table 2 ). The magnitude of these differences for both index arrhythmias is large enough to be clinically important in the interpretation of antiarrhythmic drug effects. For Another limitation of the study is that the effect of advancing age on reducing the time to recurrence could have been caused by improved compliance among older patients. Although we have no direct measure of compliance, it is our impression that compliance among our patients was high regardless of age.
Clinical Implications
Our findings suggest that the type of paroxysmal supraventricular arrhythmia and the specific mechanism of the arrhythmia are less important in predicting the frequency with which an arrhythmia recurs than is the age of the patient. This information should be considered in both the management of individual patients and the design of antiarrhythmic drug trials. The presence of a circadian distribution of tachycardia in patients with paroxysmal supraventricular tachycardia and the absence of such a distribution in paroxysmal atrial fibrillation may have implications for the administration of antiarrhythmic drugs to these two groups of patients.
